Sanofi to produce 100 million Pfizer/BioNTech vaccine doses, CEO says
Reuters | Paris | Updated: 26-01-2021 23:03 IST | Created: 26-01-2021 22:54 IST
French pharma giant Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the end of the year, CEO Paul Hudson told Le Figaro newspaper in an interview published on Tuesday.
As Sanofi and its British partner GlaxoSmithKline have delayed the launch of their shot to late 2021, the French company decided to approach Pfizer "in order to be helpful as of now", Hudson said, adding that an agreement with the U.S. company had been reached.
Advertisement
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Advertisement
ALSO READ
British lawyer Karim Khan elected next International Criminal Court prosecutor
Biden makes first trip as U.S. president to rustic Camp David retreat
U.S. Senate honors police officer who protected lawmakers in riot
Health News Roundup: UK ministers in push to boost COVID-19 vaccine uptake; Busiest U.S. seaport in California starts giving COVID-19 vaccinations and more
MEDIA-British scientists say 'universal vaccine' that could work on all COVID-19 variants could be developed in less than a year - The Telegraph